Michel Meignan
7PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 22, 2022
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II Trial.Luc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer
|Jan 06, 2022
Positron Emission Tomography-Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study.René-Olivier Casasnovas, Reda Bouabdallah, Pauline Brice
|Nov 29, 2021
Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA).Emmanuel Bachy, Vincent Camus, Catherine Thieblemont
|Apr 28, 2021
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma.Stefan Alig, Charles W Macaulay, David M Kurtz
Pageof 2
Frequent Collaborators
4 joint publications
René-Olivier Casasnovas
2 joint publications
Aspasia Stamatoullas
2 joint publications
Andreas Hüttmann
2 joint publications
Franck Morschhauser
2 joint publications
David Sibon
1 joint publications
Massimo Federico
1 joint publications
Stefan Alig
1 joint publications
Ulrich Dührsen
1 joint publications
Michael C Jin
1 joint publications
Barzin Y Nabet
